 | • レポートコード：GIR-2104Z09125 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、メタサイクリンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メタサイクリンの種類別市場規模（慢性気管支炎、リケッチア感染症、その他）、用途別市場規模（診療所、病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・メタサイクリンの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Boc Sciences、Manus Aktteva Biopharma、Cayman Chemical ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：慢性気管支炎、リケッチア感染症、その他 ・用途別分析2016年-2026年：診療所、病院 ・メタサイクリンの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・メタサイクリンのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・メタサイクリンのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・メタサイクリンの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・メタサイクリンの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Metacycline market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Metacycline size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Metacycline market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Metacycline market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Chronic Bronchitis
Rickettsial Infections
Others
Market segment by Application can be divided into
Clinics
Hospitals
The key market players for global Metacycline market are listed below:
Merck
Boc Sciences
Manus Aktteva Biopharma
Cayman Chemical
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Metacycline Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metacycline Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Chronic Bronchitis
1.2.3 Rickettsial Infections
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Metacycline Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinics
1.3.3 Hospitals
1.4 Global Metacycline Market Size & Forecast
1.4.1 Global Metacycline Sales in Value (2016-2026))
1.4.2 Global Metacycline Sales in Volume (2016-2026)
1.4.3 Global Metacycline Price by Type (2016-2026) & (USD/Kg)
1.5 Global Metacycline Production Capacity Analysis
1.5.1 Global Metacycline Total Production Capacity (2016-2026)
1.5.2 Global Metacycline Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Metacycline Market Drivers
1.6.2 Metacycline Market Restraints
1.6.3 Metacycline Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Metacycline Product and Services
2.1.4 Merck Metacycline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Boc Sciences
2.2.1 Boc Sciences Details
2.2.2 Boc Sciences Major Business
2.2.3 Boc Sciences Metacycline Product and Services
2.2.4 Boc Sciences Metacycline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Manus Aktteva Biopharma
2.3.1 Manus Aktteva Biopharma Details
2.3.2 Manus Aktteva Biopharma Major Business
2.3.3 Manus Aktteva Biopharma Metacycline Product and Services
2.3.4 Manus Aktteva Biopharma Metacycline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Cayman Chemical
2.4.1 Cayman Chemical Details
2.4.2 Cayman Chemical Major Business
2.4.3 Cayman Chemical Metacycline Product and Services
2.4.4 Cayman Chemical Metacycline Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Metacycline Sales by Manufacturer
3.1 Global Metacycline Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Metacycline Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Metacycline
3.4 Market Concentration Rate
3.4.1 Top 3 Metacycline Manufacturer Market Share
3.4.2 Top 6 Metacycline Manufacturer Market Share
3.5 Global Metacycline Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Metacycline Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Metacycline Market Size by Region
4.1.1 Global Metacycline Sales in Volume by Region (2016-2026)
4.1.2 Global Metacycline Revenue by Region (2016-2026)
4.2 North America Metacycline Revenue (2016-2026)
4.3 Europe Metacycline Revenue (2016-2026)
4.4 Asia-Pacific Metacycline Revenue (2016-2026)
4.5 South America Metacycline Revenue (2016-2026)
4.6 Middle East and Africa Metacycline Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Metacycline Sales in Volume by Type (2016-2026)
5.2 Global Metacycline Revenue by Type (2016-2026)
5.3 Global Metacycline Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Metacycline Sales in Volume by Application (2016-2026)
6.2 Global Metacycline Revenue by Application (2016-2026)
6.3 Global Metacycline Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Metacycline Sales by Type (2016-2026)
7.2 North America Metacycline Sales by Application (2016-2026)
7.3 North America Metacycline Market Size by Country
7.3.1 North America Metacycline Sales in Volume by Country (2016-2026)
7.3.2 North America Metacycline Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Metacycline Sales by Type (2016-2026)
8.2 Europe Metacycline Sales by Application (2016-2026)
8.3 Europe Metacycline Market Size by Country
8.3.1 Europe Metacycline Sales in Volume by Country (2016-2026)
8.3.2 Europe Metacycline Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Metacycline Sales by Type (2016-2026)
9.2 Asia-Pacific Metacycline Sales by Application (2016-2026)
9.3 Asia-Pacific Metacycline Market Size by Region
9.3.1 Asia-Pacific Metacycline Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Metacycline Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Metacycline Sales by Type (2016-2026)
10.2 South America Metacycline Sales by Application (2016-2026)
10.3 South America Metacycline Market Size by Country
10.3.1 South America Metacycline Sales in Volume by Country (2016-2026)
10.3.2 South America Metacycline Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Metacycline Sales by Type (2016-2026)
11.2 Middle East & Africa Metacycline Sales by Application (2016-2026)
11.3 Middle East & Africa Metacycline Market Size by Country
11.3.1 Middle East & Africa Metacycline Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Metacycline Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Metacycline Typical Distributors
12.3 Metacycline Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Metacycline Revenue by Type, (USD Million), 2021-2026
Table 2. Global Metacycline Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Metacycline Product and Services
Table 6. Merck Metacycline Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Boc Sciences Basic Information, Manufacturing Base and Competitors
Table 8. Boc Sciences Major Business
Table 9. Boc Sciences Metacycline Product and Services
Table 10. Boc Sciences Metacycline Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Manus Aktteva Biopharma Basic Information, Manufacturing Base and Competitors
Table 12. Manus Aktteva Biopharma Major Business
Table 13. Manus Aktteva Biopharma Metacycline Product and Services
Table 14. Manus Aktteva Biopharma Metacycline Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 16. Cayman Chemical Major Business
Table 17. Cayman Chemical Metacycline Product and Services
Table 18. Cayman Chemical Metacycline Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Metacycline Sales by Manufacturer (2019-2021e) & (MT)
Table 20. Global Metacycline Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Metacycline, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Metacycline Production Capacity by Company, (MT): 2020 VS 2021
Table 23. Head Office and Metacycline Production Site of Key Manufacturer
Table 24. Global Metacycline Sales by Region (2016-2021e) & (MT)
Table 25. Global Metacycline Sales by Region (2021-2026) & (MT)
Table 26. Global Metacycline Revenue by Region (2016-2021e) & (USD Million)
Table 27. Global Metacycline Revenue by Region (2021-2026) & (USD Million)
Table 28. Global Metacycline Sales by Type (2016-2021e) & (MT)
Table 29. Global Metacycline Sales by Type (2021-2026) & (MT)
Table 30. Global Metacycline Revenue by Type (2016-2021e) & (USD Million)
Table 31. Global Metacycline Revenue by Type (2021-2026) & (USD Million)
Table 32. Global Metacycline Price by Type (2016-2021e) & (USD/Kg)
Table 33. Global Metacycline Price by Type (2021-2026) & (USD/Kg)
Table 34. Global Metacycline Sales by Application (2016-2021e) & (MT)
Table 35. Global Metacycline Sales by Application (2021-2026) & (MT)
Table 36. Global Metacycline Revenue by Application (2016-2021e) & (USD Million)
Table 37. Global Metacycline Revenue by Application (2021-2026) & (USD Million)
Table 38. Global Metacycline Price by Application (2016-2021e) & (USD/Kg)
Table 39. Global Metacycline Price by Application (2021-2026) & (USD/Kg)
Table 40. North America Metacycline Sales by Country (2016-2021e) & (MT)
Table 41. North America Metacycline Sales by Country (2021-2026) & (MT)
Table 42. North America Metacycline Revenue by Country (2016-2021e) & (USD Million)
Table 43. North America Metacycline Revenue by Country (2021-2026) & (USD Million)
Table 44. North America Metacycline Sales by Type (2016-2021e) & (MT)
Table 45. North America Metacycline Sales by Type (2021-2026) & (MT)
Table 46. North America Metacycline Sales by Application (2016-2021e) & (MT)
Table 47. North America Metacycline Sales by Application (2021-2026) & (MT)
Table 48. Europe Metacycline Sales by Country (2016-2021e) & (MT)
Table 49. Europe Metacycline Sales by Country (2021-2026) & (MT)
Table 50. Europe Metacycline Revenue by Country (2016-2021e) & (USD Million)
Table 51. Europe Metacycline Revenue by Country (2021-2026) & (USD Million)
Table 52. Europe Metacycline Sales by Type (2016-2021e) & (MT)
Table 53. Europe Metacycline Sales by Type (2021-2026) & (MT)
Table 54. Europe Metacycline Sales by Application (2016-2021e) & (MT)
Table 55. Europe Metacycline Sales by Application (2021-2026) & (MT)
Table 56. Asia-Pacific Metacycline Sales by Region (2016-2021e) & (MT)
Table 57. Asia-Pacific Metacycline Sales by Region (2021-2026) & (MT)
Table 58. Asia-Pacific Metacycline Revenue by Region (2016-2021e) & (USD Million)
Table 59. Asia-Pacific Metacycline Revenue by Region (2021-2026) & (USD Million)
Table 60. Asia-Pacific Metacycline Sales by Type (2016-2021e) & (MT)
Table 61. Asia-Pacific Metacycline Sales by Type (2021-2026) & (MT)
Table 62. Asia-Pacific Metacycline Sales by Application (2016-2021e) & (MT)
Table 63. Asia-Pacific Metacycline Sales by Application (2021-2026) & (MT)
Table 64. South America Metacycline Sales by Country (2016-2021e) & (MT)
Table 65. South America Metacycline Sales by Country (2021-2026) & (MT)
Table 66. South America Metacycline Revenue by Country (2016-2021e) & (USD Million)
Table 67. South America Metacycline Revenue by Country (2021-2026) & (USD Million)
Table 68. South America Metacycline Sales by Type (2016-2021e) & (MT)
Table 69. South America Metacycline Sales by Type (2021-2026) & (MT)
Table 70. South America Metacycline Sales by Application (2016-2021e) & (MT)
Table 71. South America Metacycline Sales by Application (2021-2026) & (MT)
Table 72. Middle East & Africa Metacycline Sales by Country (2016-2021e) & (MT)
Table 73. Middle East & Africa Metacycline Sales by Country (2021-2026) & (MT)
Table 74. Middle East & Africa Metacycline Revenue by Country (2016-2021e) & (USD Million)
Table 75. Middle East & Africa Metacycline Revenue by Country (2021-2026) & (USD Million)
Table 76. Middle East & Africa Metacycline Sales by Type (2016-2021e) & (MT)
Table 77. Middle East & Africa Metacycline Sales by Type (2021-2026) & (MT)
Table 78. Middle East & Africa Metacycline Sales by Application (2016-2021e) & (MT)
Table 79. Middle East & Africa Metacycline Sales by Application (2021-2026) & (MT)
Table 80. Direct Channel Pros & Cons
Table 81. Indirect Channel Pros & Cons
Table 82. Metacycline Typical Distributors
Table 83. Metacycline Typical Customers
List of Figures
Figure 1. Metacycline Picture
Figure 2. Global Metacycline Sales Market Share by Type in 2020
Figure 3. Chronic Bronchitis
Figure 4. Rickettsial Infections
Figure 5. Others
Figure 6. Global Metacycline Sales Market Share by Application in 2020
Figure 7. Clinics
Figure 8. Hospitals
Figure 9. Global Metacycline Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 10. Global Metacycline Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Metacycline Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Metacycline Sales (2016-2026) & (MT)
Figure 31. Global Metacycline Production Capacity (2016-2026) & (MT)
Figure 32. Global Metacycline Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Metacycline Market Drivers
Figure 34. Metacycline Market Restraints
Figure 35. Metacycline Market Trends
Figure 36. Global Metacycline Sales Market Share by Manufacturer in 2020
Figure 37. Global Metacycline Revenue Market Share by Manufacturer in 2020
Figure 38. Metacycline Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Metacycline Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Metacycline Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Metacycline Sales Market Share by Region (2016-2026)
Figure 42. Global Metacycline Revenue Market Share by Region (2016-2026)
Figure 43. North America Metacycline Revenue (2016-2026) & (USD Million)
Figure 44. Europe Metacycline Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Metacycline Revenue (2016-2026) & (USD Million)
Figure 46. South America Metacycline Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Metacycline Revenue (2016-2026) & (USD Million)
Figure 48. Global Metacycline Sales Market Share by Type (2016-2026)
Figure 49. Global Metacycline Revenue Market Share by Type (2016-2026)
Figure 50. Global Metacycline Price by Type (2016-2026) & (USD/Kg)
Figure 51. Global Metacycline Sales Market Share by Application (2016-2026)
Figure 52. Global Metacycline Revenue Market Share by Application (2016-2026)
Figure 53. Global Metacycline Price by Application (2016-2026) & (USD/Kg)
Figure 54. North America Metacycline Sales Market Share by Country (2016-2026)
Figure 55. North America Metacycline Revenue Market Share by Country (2016-2026)
Figure 56. North America Metacycline Sales Market Share by Type (2016-2026)
Figure 57. North America Metacycline Sales Market Share by Application (2016-2026)
Figure 58. Europe Metacycline Sales Market Share by Country (2016-2026)
Figure 59. Europe Metacycline Revenue Market Share by Country (2016-2026)
Figure 60. Europe Metacycline Sales Market Share by Type (2016-2026)
Figure 61. Europe Metacycline Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Metacycline Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Metacycline Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Metacycline Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Metacycline Sales Market Share by Application (2016-2026)
Figure 66. South America Metacycline Sales Market Share by Country (2016-2026)
Figure 67. South America Metacycline Revenue Market Share by Country (2016-2026)
Figure 68. South America Metacycline Sales Market Share by Type (2016-2026)
Figure 69. South America Metacycline Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Metacycline Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Metacycline Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Metacycline Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Metacycline Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界の気管支炎治療市場規模・現状・予測（2021年-2027年） Bronchitis is a respiratory disease in which there is inflammation of the bronchi in the lungs. In other words, bronchitis is an inflammation of the lining of bronchial tubes that carry air to and from the lungs. Some of the common signs and symptoms of bronchitis include cough, fatigue, shortness o…- 世界の気管支炎市場規模・現状・予測（2021年-2027年） Bronchitis is inflammation of the bronchi (large and medium-sized airways) in the lungs. Symptoms include coughing up mucus, wheezing, shortness of breath, and chest discomfort. Bronchitis is divided into two types: acute and chronic. Acute bronchitis is also known as a chest cold. Market Analysis a…
- 世界の壊死性皮膚感染症治療市場規模・現状・予測（2021年-2027年） Necrotizing skin infections ranks among the most rarely found diseases but are highly lethal infection. Necrotizing skin infection arise primarily in any layer of skin soft tissue such as dermis and epidermis that are associated with necrotizing changes. Necrotizing skin infection is also commonly c…
- 世界の目感染症治療市場規模・現状・予測（2021年-2027年） Eye infections can be the inflammation of the Conjunctiva (Conjunctivitis), eyelid (blepharitis), the cornea (keratitis), the liquid inside the eye (vitritis), the retina and the blood vessels that feed it (chorioretinitis), or the optic nerve (neuroretinitis). Eye infections treatment market is gro…
- 世界の院内感染症（HAI）診断市場規模・現状・予測（2021年-2027年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…